BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 22127080)

  • 1. D2 lymph node dissection improves staging in patients with gastric adenocarcinoma.
    Putchakayala K; Difronzo LA
    Am Surg; 2011 Oct; 77(10):1326-9. PubMed ID: 22127080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
    Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
    Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
    Roukos DH; Lorenz M; Encke A
    Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive D2 lymphadenectomy is required for accurate pathologic staging of gastric adenocarcinoma.
    Smith BR; Stabile BE
    Am Surg; 2006 Oct; 72(10):849-52. PubMed ID: 17058719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasis in para-aortic lymph nodes in patients with advanced gastric cancer, treated with extended lymphadenectomy.
    Yonemura Y; Wu CC; Fukushima N; Honda I; Bandou E; Kawamura T; Kamata S; Yamamoto H; Kim BS; Matsuki N; Sawa T; Noh SH;
    Hepatogastroenterology; 2007 Mar; 54(74):634-8. PubMed ID: 17523339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of D1 and D2 ganglionic dissection in advanced gastric cancer at Rebagliati Hospital].
    Cornejo C; Portanova M
    Rev Gastroenterol Peru; 2006; 26(4):351-6. PubMed ID: 17211484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution.
    Kasakura Y; Mochizuki F; Wakabayashi K; Kochi M; Fujii M; Takayama T
    J Surg Res; 2002 Apr; 103(2):252-9. PubMed ID: 11922742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of superextended lymphadenectomy (D4) in gastric cancer].
    Pugliese R; Maggioni D; Sansonna F; Scandroglio I; Di Lernia S; Boniardi M; Bramerio MA
    Minerva Chir; 2004 Aug; 59(4):325-35. PubMed ID: 15278027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the prognostic value of UICC and JGCA lymph node staging criteria for gastric cancer].
    Pan Y; Liang H; Xue Q; Zhang RP; Cui QH; Liu N; Wang BG
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):376-80. PubMed ID: 18953840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended lymphadenectomy (D2) in patients with early gastric cancer.
    Nitti D; Marchet A; Mammano E; Ambrosi A; Belluco C; Mencarelli R; Maino M; Marconato G; Farinati F; Lise M
    Eur J Surg Oncol; 2005 Oct; 31(8):875-81. PubMed ID: 16051460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node metastasis with adenocarcinoma of the gastric cardia: clinicopathological analysis and indication for D1 dissection.
    Shimada H; Suzuki T; Nakajima K; Hori S; Hayashi H; Takeda A; Arima M; Gunji Y; Koide Y; Ochiai T
    Int Surg; 1999; 84(1):13-7. PubMed ID: 10421011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric carcinoma: does lymph node dissection alter survival?
    Wanebo HJ; Kennedy BJ; Winchester DP; Fremgen A; Stewart AK
    J Am Coll Surg; 1996 Dec; 183(6):616-24. PubMed ID: 8957465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D2 lymphadenectomy with surgical ex vivo dissection into node stations for gastric adenocarcinoma can be performed safely in Western patients and ensures optimal staging.
    Schmidt B; Chang KK; Maduekwe UN; Look-Hong N; Rattner DW; Lauwers GY; Mullen JT; Yang HK; Yoon SS
    Ann Surg Oncol; 2013 Sep; 20(9):2991-9. PubMed ID: 23760588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical outcome of 801 patients with localized gastric cancer treated with d2 lymphadenectomy].
    Ruiz E; Sanchez J; Celis J; Payet E; Berrospi F; Chavez I; Young F
    Rev Gastroenterol Peru; 2009; 29(2):124-31. PubMed ID: 19609327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.
    Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC
    Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic outcomes of laparoscopy-assisted distal gastrectomy for gastric cancer.
    Fukunaga T; Hiki N; Kubota T; Nunobe S; Tokunaga M; Nohara K; Sano T; Yamaguchi T
    Ann Surg Oncol; 2013 Aug; 20(8):2676-82. PubMed ID: 23709054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
    Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
    Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.